2-69338431-TAA-TA
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001244710.2(GFPT1):c.1324+13delT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.148 in 1,606,626 control chromosomes in the GnomAD database, including 18,915 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.13 ( 1400 hom., cov: 30)
Exomes 𝑓: 0.15 ( 17515 hom. )
Consequence
GFPT1
NM_001244710.2 intron
NM_001244710.2 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.763
Genes affected
GFPT1 (HGNC:4241): (glutamine--fructose-6-phosphate transaminase 1) This gene encodes the first and rate-limiting enzyme of the hexosamine pathway and controls the flux of glucose into the hexosamine pathway. The product of this gene catalyzes the formation of glucosamine 6-phosphate. [provided by RefSeq, Sep 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 2-69338431-TA-T is Benign according to our data. Variant chr2-69338431-TA-T is described in ClinVar as [Likely_benign]. Clinvar id is 257667.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-69338431-TA-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.157 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFPT1 | NM_001244710.2 | c.1324+13delT | intron_variant | ENST00000357308.9 | NP_001231639.1 | |||
GFPT1 | NM_002056.4 | c.1270+13delT | intron_variant | NP_002047.2 | ||||
GFPT1 | XM_017003801.2 | c.1399+13delT | intron_variant | XP_016859290.1 | ||||
GFPT1 | XM_017003802.3 | c.1345+13delT | intron_variant | XP_016859291.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GFPT1 | ENST00000357308.9 | c.1324+13delT | intron_variant | 5 | NM_001244710.2 | ENSP00000349860.4 | ||||
GFPT1 | ENST00000361060.5 | c.1270+13delT | intron_variant | 1 | ENSP00000354347.4 | |||||
GFPT1 | ENST00000674507.1 | c.1270+13delT | intron_variant | ENSP00000501332.1 | ||||||
GFPT1 | ENST00000674438.1 | c.1054+13delT | intron_variant | ENSP00000501469.1 |
Frequencies
GnomAD3 genomes AF: 0.128 AC: 19434AN: 152104Hom.: 1400 Cov.: 30
GnomAD3 genomes
AF:
AC:
19434
AN:
152104
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.123 AC: 30767AN: 250048Hom.: 2155 AF XY: 0.127 AC XY: 17218AN XY: 135124
GnomAD3 exomes
AF:
AC:
30767
AN:
250048
Hom.:
AF XY:
AC XY:
17218
AN XY:
135124
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.150 AC: 218191AN: 1454404Hom.: 17515 Cov.: 27 AF XY: 0.150 AC XY: 108737AN XY: 723904
GnomAD4 exome
AF:
AC:
218191
AN:
1454404
Hom.:
Cov.:
27
AF XY:
AC XY:
108737
AN XY:
723904
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.128 AC: 19438AN: 152222Hom.: 1400 Cov.: 30 AF XY: 0.125 AC XY: 9294AN XY: 74426
GnomAD4 genome
AF:
AC:
19438
AN:
152222
Hom.:
Cov.:
30
AF XY:
AC XY:
9294
AN XY:
74426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
310
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Congenital Myasthenic Syndrome, Recessive Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 29, 2018 | - - |
Congenital myasthenic syndrome 12 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at